lorazepam has been researched along with Ornithine Carbamoyltransferase Deficiency Disease in 1 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Ornithine Carbamoyltransferase Deficiency Disease: An inherited urea cycle disorder associated with deficiency of the enzyme ORNITHINE CARBAMOYLTRANSFERASE, transmitted as an X-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. (Menkes, Textbook of Child Neurology, 5th ed, pp49-50)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaspari, R | 1 |
| Arcangeli, A | 1 |
| Mensi, S | 1 |
| Wismayer, DS | 1 |
| Tartaglione, T | 1 |
| Antuzzi, D | 1 |
| Conti, G | 1 |
| Proietti, R | 1 |
1 other study available for lorazepam and Ornithine Carbamoyltransferase Deficiency Disease
| Article | Year |
|---|---|
Late-onset presentation of ornithine transcarbamylase deficiency in a young woman with hyperammonemic coma.
Topics: Adult; Age Factors; Anticonvulsants; Brain; Citrulline; Coma; Diagnosis, Differential; Electroenceph | 2003 |